Cargando…
Temsirolimus, interferon alfa or both in advanced renal-cell carcinoma: One plus one does not always equal two
Autores principales: | Grover, S., Singh, J. C., Kekre, N. S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721624/ https://www.ncbi.nlm.nih.gov/pubmed/19718348 |
Ejemplares similares
-
Transplantation of kidneys with small renal tumors: A novel idea?
por: Grover, Sameer, et al.
Publicado: (2009) -
Does tamsulosin facilitate expulsion of distal ureteric calculus following lithotripsy?
por: Gupta, Gaurav, et al.
Publicado: (2008) -
Does dutasteride reduce perioperative blood loss and postoperative complications after transurethral resection of the prostate?
por: Shanmugasundaram, R., et al.
Publicado: (2007) -
Which one is better, Wallace or Bricker?
por: Khurana, Naval, et al.
Publicado: (2007) -
Long-term follow-up results of nivolumab plus cabozantinib versus sunitinib for advanced renal cell cancer: Checkmate 9ER trial
por: Tarigopula, Vivek
Publicado: (2022)